About Gene to Health Limited
Gene to Health LimitedFounded in March 2022 and officially established in October 2023, our company is a trailblazer in the field of statistical genetics and polygenic scoring. The organization is led by Dr. CHEN Guolan (Founder & CEO), who holds a PhD in Statistical Genetics & Machine Learning from the University of Hong Kong (HKU) and a B.S. in Biostatistics from Fudan University. Co-founder and principal technical advisor, Dr. Justin D. Tubbs, is currently a Postdoc at Harvard Medical School with a PhD in Behavioral Genetics & Bioinformatics from HKU.
